Indian researchers at NIT Rourkela develop a low-cost, highly precise TFET-based device for early breast cancer ...

A recent report found that women account for two-thirds of all cancers diagnosed in people under 50. But it's not all bad ...

Researchers at National Institute of Technology (NIT), Rourkela have developed a novel semiconductor device-based biosensor that can identify breast cancer cells without the need for complicated or ...

By Dennis Thompson HealthDay ReporterFRIDAY, May 23, 2025 (HealthDay News) — Alcohol-fueled cancer deaths nearly doubled in ...

Researchers have investigated a novel semiconductor device-based biosensor that can identify breast cancer cells without the need for complicated or expensive laboratory procedu ...

A new large analysis led by American Cancer Society (ACS) researchers shows engaging in leisure-time moderate-to-vigorous ...

Researchers have discovered a set of alterations in the structure and cellular makeup of breast connective tissue – known as ...

Joe Biden’s critics have rushed to judgment, which is never wise, and even less so in frightening medical situations.

The Itovebi-based regimen is approved for the treatment of adults with endocrine-resistant, PIK3CA -mutated, HR-positive, ...

INAVO120 trial shows inavolisib, palbociclib, and fulvestrant significantly improved overall survival in PIK3CA-mutant ...

World Cancer Research Fund International supports research on how diet, weight, and physical activity affect cancer risk and ...